What's Hot

This week, Genetic Engineering & Biotechnology News' Harry Glorikian and Brian Clancy round up what they call "sequencing trends worth watching." The first, they say, is the polarization of sequencing activity — "an increasing share of total high-throughput sequencing activity being conducted by the largest and smallest sequencing labs … driven by a series of centralization and decentralization forces that are acting on the space simultaneously." Glorikian and Clancy sug

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The US Food and Drug Administration has new guidelines that enable some gene and cell therapies to undergo expedited review, according to the New York Times.

Using gene drives to control invasive species might be too risky, an initial advocate of the approach says.

In Science this week: intellectual property experts argue patent battles such as the one over CRISPR are wasteful, and more.

Researchers have grown tumors in 3D cell cultures to better understand cancer, the Economist reports.